Results 121 to 130 of about 1,905 (169)

Schisandrin B promotes hepatic differentiation from human umbilical cord mesenchymal stem cells. [PDF]

iScience
Jin M, Yi X, Zhu X, Hu W, Wang S, Chen Q, Yang W, Li Y, Li S, Peng Q, Pan M, Gao Y, Xu S, Zhang Y, Zhou S.   +14 more
europepmc   +1 more source

Schisandrin B Suppresses Colon Cancer Growth by Inducing Cell Cycle Arrest and Apoptosis: Molecular Mechanism and Therapeutic Potential. [PDF]

ACS Pharmacol Transl Sci
Co VA, El-Nezami H, Liu Y, Twum B, Dey P, Cox PA, Joseph S, Agbodjan-Dossou R, Sabzichi M, Draheim R, Wan MLY.   +10 more
europepmc   +1 more source

Schisandrin B Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss. [PDF]

Front Pharmacol, 2020
Wang J, Fang Z, Song C, Kang H, Guo Q, Dong Y, Zhang Y, Peng R, Guan H, Li F.   +9 more
europepmc   +1 more source

The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production. [PDF]

Biomolecules
Chang CM, Liang TR, Lam HYP.
europepmc   +1 more source

[Retracted] Schisandrin B inhibits epithelial‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways. [PDF]

Oncol Rep
Li S, Wang H, Ma R, Wang L.
europepmc   +1 more source

Schisandrin B, a dual positive allosteric modulator of GABA_A and glycine receptors, alleviates seizures in multiple mouse models. [PDF]

Acta Pharmacol Sin
Wu J, Zhao M, Jin YC, Li M, Yu KX, Yu HB.   +5 more
europepmc   +1 more source

A novel experimental model of acute hypertriglyceridemia induced by schisandrin B

European Journal of Pharmacology, 2006
Mice were intragastrically treated with single doses (0.05-0.8 g/kg) of schisandrin B (a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis). Twenty-four hours after schisandrin B administration, the serum triglyceride level was increased by 10-235% in a dose-dependent manner.
Si-Yuan Pan, Yifan Han, Wen-Yuan Li
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Schisandrin B—A novel inhibitor of P-glycoprotein

Biochemical and Biophysical Research Communications, 2005
P-glycoprotein-mediated drug efflux is one of the major causes of the cancer multidrug resistance (MDR). Inhibition of P-glycoprotein could reverse cancer MDR. Here, we show that schisandrin B, a naturally occurring compound from Schisandra chinensis (Turcz.) Baill, bears strong potency to inhibit P-glycoprotein.
Xun Hu
exaly   +3 more sources

Schisandrin B protects against solar irradiation-induced oxidative stress in rat skin tissue

Fìtoterapìâ, 2011
Schisandrin B (Sch B) and schisandrin C (Sch C), but not schisandrin A and dimethyl diphenyl bicarboxylate, protected rat skin tissue against solar irradiation-induced oxidative injury, as evidenced by a reversal of solar irradiation-induced changes in ...
Philip Y Lam, Hoi Yan Leung, Kam Ming Ko
exaly   +2 more sources

Schisandrin B promotes TH1 cell differentiation by targeting STAT1

International Immunopharmacology, 2021
Schisandrin B (Sch B) is the major active ingredient of the traditional Chinese medicine Schisandra chinensis and has antitumor activity, anti-inflammatory activity. CD4+ Th subsets orchestrate immune responses to plenty of pathogen infections and participate in the pathogenesis of many immune-related diseases.
Jufeng Guo, Yingying Shen, Xia Lin, Honggang Chen, Jian Liu   +4 more
openaire   +2 more sources